CMV monoclonal antibody (Scotgen Biopharmaceuticals)

N/A

Report date: 2023/01/14 14:15:24

Base Information

Drug NameCMV monoclonal antibody (Scotgen Biopharmaceuticals)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCytomegalovirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesScotgen [Ceased]
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesScotgen [Ceased]
Active IndicationsN/A
Inactive IndicationsCytomegalovirus Infections

Other Information

ATC CodeN/A
Related LinksN/A